17-(((((6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-6,9-DIFLUORO-11,17-DIHYDROXY-16-METHYL-3-OXOANDROSTA-1,4-DIEN-17-YL)CARBONYL)DITHIO)CARBONYL)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIEN-3-ONE
UNII ETY5QGU5JY
Substance Identification & Data
This profile provides standardized clinical and technical data for 17-(((((6.alpha.,11.beta.,16.alpha.,17.alpha.)-6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl)carbonyl)dithio)carbonyl)-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)androsta-1,4-dien-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ETY5QGU5JY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 201812-62-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C45H54F4O9S2 XADXWXXIGXPRNO-SBIVQUOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 17-(((((6.alpha.,11.beta.,16.alpha.,17.alpha.)-6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl)carbonyl)dithio)carbonyl)-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)androsta-1,4-dien-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.